Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Rezatapopt is a reactivator of p53 containing a tyrosine-to-cysteine substitution at position 220 (p53Y220C).1 It stabilizes the conformation of p53Y220C, induces sequence-specific DNA binding, and restores wild-type p53 function.2 Rezatapopt decreases the proliferation of NUGC-3 gastric carcinoma cells (IC50 = 504 nM).1 It also reduces tumor growth in an NUGC-3 mouse xenograft model at 25 and 50 mg/kg and induces tumor regression at 100 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery of rezatapopt (PC14586), a first-
2. Restoration of the tumor suppressor function of Y220C-